Aptevo Therapeutics Inc. Business Finance Contracts & Agreements
102 Contracts & Agreements
- Contribution Agreements (1 contract)
- Credit Agreements (4)
- Equity Distribution Agreements (13)
- Modification Agreements (7)
- Note Agreements (1)
- Purchase Agreements (19)
- Registration Rights Agreements (4)
- Release Agreements (1)
- Security Agreements (1)
- Stock Agreements (1)
- Underwriting Agreements (3)
- Warrant Agreements (47)
Recent Contracts
Category
Company
Industry
Jur.
Filed
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
NY
2025
Aptevo Therapeutics Inc.
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
2024
Aptevo Therapeutics Inc.
2024
Aptevo Therapeutics Inc.
2024
Aptevo Therapeutics Inc.
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
NY
2024
Aptevo Therapeutics Inc.
2024
Series B-1 Common Stock Purchase Warrant between Aptevo Therapeutics Inc. and Holder (November 2023)
Aptevo Therapeutics Inc.
2024
Series A-2 Common Stock Purchase Warrant between Aptevo Therapeutics Inc. and Holder (November 2023)
Aptevo Therapeutics Inc.
2024
Series A-1 Common Stock Purchase Warrant between Aptevo Therapeutics Inc. and Holder (November 2023)
Aptevo Therapeutics Inc.
2024
Aptevo Therapeutics Inc.
2024
Aptevo Therapeutics Inc.
NY
2024